Further investigation into the relationship between LOXL3 and the Wnt/β-catenin signaling pathway in glioma will help elucidate the underlying mechanisms of gliomagenesis and provide new targets and insights for developing more effective therapeutic strategies. The gene discussed is LOXL3; the disease is central nervous system cancer.